115 related articles for article (PubMed ID: 36245435)
21. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice.
Csete D; Simon E; Alatshan A; Aradi P; Dobó-Nagy C; Jakus Z; Benkő S; Győri DS; Mócsai A
Front Immunol; 2019; 10():937. PubMed ID: 31134061
[TBL] [Abstract][Full Text] [Related]
23. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
24. A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair.
Walia B; Lingenheld E; Duong L; Sanjay A; Drissi H
Ann N Y Acad Sci; 2018 Mar; 1415(1):57-68. PubMed ID: 29479711
[TBL] [Abstract][Full Text] [Related]
25. Mouse mandibular-derived osteoclast progenitors have differences in intrinsic properties compared with femoral-derived progenitors.
Clark R; Park SY; Bradley EW; Mansky K; Tasca A
JBMR Plus; 2024 May; 8(5):ziae029. PubMed ID: 38606149
[TBL] [Abstract][Full Text] [Related]
26. Articular cartilage protection in Ctsk
Soki FN; Yoshida R; Paglia DN; Duong LT; Hansen MF; Drissi H
J Cell Physiol; 2018 Nov; 233(11):8666-8676. PubMed ID: 29781506
[TBL] [Abstract][Full Text] [Related]
27. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.
Yang Y; Chung MR; Zhou S; Gong X; Xu H; Hong Y; Jin A; Huang X; Zou W; Dai Q; Jiang L
J Biol Chem; 2019 Oct; 294(42):15395-15407. PubMed ID: 31462535
[TBL] [Abstract][Full Text] [Related]
28. Deletion of Wnt5a in osteoclasts results in bone loss through decreased bone formation.
Roberts JL; Liu G; Paglia DN; Kinter CW; Fernandes LM; Lorenzo J; Hansen MF; Arif A; Drissi H
Ann N Y Acad Sci; 2020 Mar; 1463(1):45-59. PubMed ID: 31919867
[TBL] [Abstract][Full Text] [Related]
29. Geometric morphometrics of different malocclusions in lateral skull radiographs.
Freudenthaler J; Čelar A; Ritt C; Mitteröcker P
J Orofac Orthop; 2017 Jan; 78(1):11-20. PubMed ID: 27796401
[TBL] [Abstract][Full Text] [Related]
30. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
[TBL] [Abstract][Full Text] [Related]
31. The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth.
Touaitahuata H; Cres G; de Rossi S; Vives V; Blangy A
Dev Biol; 2014 Sep; 393(1):57-70. PubMed ID: 24992711
[TBL] [Abstract][Full Text] [Related]
32. Effects of anti-RANKL antibodies administered to pregnant mice on bone and tooth development in neonates.
Yamaguchi M; Takami M; Azetsu Y; Karakawa A; Chatani M; Funatsu T; Sakai N
J Oral Biosci; 2023 Jun; 65(2):186-194. PubMed ID: 36907379
[TBL] [Abstract][Full Text] [Related]
33. Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton.
Das BK; Wang L; Fujiwara T; Zhou J; Aykin-Burns N; Krager KJ; Lan R; Mackintosh SG; Edmondson R; Jennings ML; Wang X; Feng JQ; Barrientos T; Gogoi J; Kannan A; Gao L; Xing W; Mohan S; Zhao H
Elife; 2022 Jun; 11():. PubMed ID: 35758636
[TBL] [Abstract][Full Text] [Related]
34. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
Chen W; Zhu G; Tang J; Zhou HD; Li YP
J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells.
Vashum Y; Kottaiswamy A; Bupesh G; Singh RP; Kalaiselvan P; Thiagarajan K; Samuel S
Curr Mol Pharmacol; 2021; 14(6):1134-1145. PubMed ID: 33573566
[TBL] [Abstract][Full Text] [Related]
36. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW
PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773
[TBL] [Abstract][Full Text] [Related]
37. Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.
Molstad DHH; Mattson AM; Begun DL; Westendorf JJ; Bradley EW
J Biol Chem; 2020 Dec; 295(51):17713-17723. PubMed ID: 33454009
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of osteoclast activity and bone turnover in different skeletal sites.
Goldberg S; Grynpas MD; Glogauer M
Arch Oral Biol; 2016 Nov; 71():134-143. PubMed ID: 27505033
[TBL] [Abstract][Full Text] [Related]
39. EphA4 receptor is a novel negative regulator of osteoclast activity.
Stiffel V; Amoui M; Sheng MH; Mohan S; Lau KH
J Bone Miner Res; 2014 Apr; 29(4):804-19. PubMed ID: 23983218
[TBL] [Abstract][Full Text] [Related]
40. Altering calcium and phosphorus supplementation in pregnancy and lactation affects offspring craniofacial morphology in a sex-specific pattern.
Hassan MG; Chen C; Ismail HA; Zaher AR; Cox TC; Goodwin AF; Jheon AH
Am J Orthod Dentofacial Orthop; 2022 May; 161(5):e446-e455. PubMed ID: 35131118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
